Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

About the company

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

68

$1.00M

Total Revenue

68

Employees

$414.72M

Market Capitalization

-7.11

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-4M

Net Margin (in %)

Total net margin

$-4M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382757.45 82729.00 6.15 22.31 20.75
Merck & Co., Inc. MRK 204202.28 48081.00 7.67 20.15 21.10
Pfizer Inc. PFE 194670.90 50660.00 2.95 12.32 31.17
Eli Lilly & Co. LLY 153205.02 23087.00 51.99 27.00 23.97
AbbVie, Inc. ABBV 146930.84 34057.00 -23.52 17.52 24.65
Bristol Myers Squibb Co. BMY 110414.38 31006.00 2.68 93.87 3.08
Repligen Corp. RGEN 6456.09 286.00 6.19 281.31 8.11
Reata Pharmaceuticals, Inc. RETA 4973.33 20.00 23.56 -16.00 -150.30
Nektar Therapeutics NKTR 4220.48 137.00 3.29 -9.19 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3721.12 1.00 34.40 -5.69 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2642.22 2.00 31.17 -22.65 None
OPKO Health, Inc. OPK 2289.84 891.00 1.63 -7.83 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1681.30 None 5.46 -26.97 None
Principia Biopharma, Inc. PRNB 1604.12 30.00 5.71 -22.82 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Zymeworks, Inc. ZYME 1511.16 26.00 3.14 -8.91 -629.37
Akcea Therapeutics, Inc. AKCA 1370.61 341.00 2.81 -48.72 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1301.44 None 6.69 -6.16 None
Arcutis Biotherapeutics, Inc. ARQT 1194.36 None 5.09 -19.10 None
Odonate Therapeutics, Inc. ODT 1150.14 None 9.42 -10.22 None
Phibro Animal Health Corp. PAHC 1077.48 818.00 5.44 29.20 4.49
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Akero Therapeutics, Inc. AKRO 1013.84 None 8.46 -19.98 None
Constellation Pharmaceuticals, Inc. CNST 925.12 None 4.35 -9.97 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Phathom Pharmaceuticals, Inc. PHAT 808.50 None 4.49 -2.97 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Aprea Therapeutics, Inc. APRE 769.86 None 6.81 -22.77 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 690.14 14.00 4.46 -14.00 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Keros Therapeutics, Inc. KROS 623.16 8.00 -28.15 -29.34 -285.35
Amneal Pharmaceuticals, Inc. AMRX 619.24 1679.00 4.26 -2.84 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 605.28 19.00 56.10 -21.76 -151.34
Oyster Point Pharma, Inc. OYST 596.40 None 5.99 -10.36 None
Mirum Pharmaceuticals, Inc. MIRM 505.00 None 3.28 -7.45 None
SIGA Technologies, Inc. SIGA 480.11 19.00 5.37 -24.40 -94.00
Satsuma Pharmaceuticals, Inc. STSA 463.25 None 4.56 -12.73 None
Imara, Inc. IMRA 461.21 None 4.45 -13.11 None
Biospecifics Technologies Corp. BSTC 436.17 40.00 3.54 18.66 61.80
Fulcrum Therapeutics, Inc. FULC 419.75 1.00 7.07 -6.08 None
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
89bio, Inc. ETNB 386.40 None 4.77 -5.99 None
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 379.08 6.00 4.15 -4.13 None
Relmada Therapeutics, Inc. RLMD 377.19 0.00 5.63 -31.51 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 321.75 None 7.61 -4.93 None
Urovant Sciences Ltd. UROV 301.80 None -5.35 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
AMAG Pharmaceuticals, Inc. AMAG 281.52 321.00 1.08 -0.76 -115.05
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
Lannett Co., Inc. LCI 270.18 542.00 0.92 -8.89 -5.77
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Spero Therapeutics, Inc. SPRO 254.03 12.00 3.34 -3.12 -656.72
Gritstone Oncology, Inc. GRTS 240.84 4.00 2.16 -2.31 None
KalVista Pharmaceuticals, Inc. KALV 233.46 12.00 2.58 -7.21 -263.38
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
Veru, Inc. VERU 211.90 39.00 7.09 -21.73 -25.53
LogicBio Therapeutics, Inc. LOGC 184.69 1.00 5.58 -4.34 None
Galera Therapeutics, Inc. GRTX 183.75 None 3.43 -2.79 None
Liquidia Technologies, Inc. LQDA 171.38 8.00 10.12 -3.48 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 166.14 None 2.50 -10.77 None
Avenue Therapeutics, Inc. ATXI 161.92 532.00 29.76 -11.12 26.69
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 152.95 None 8.87 -7.00 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Harrow Health, Inc. HROW 135.72 51.00 8.70 -5.49 -47.54
Aquestive Therapeutics, Inc. AQST 131.88 49.00 -7.60 -1.88 -139.64
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
PhaseBio Pharmaceuticals, Inc. PHAS 127.31 2.00 2.36 -2.66 None
Trevi Therapeutics, Inc. TRVI 125.64 None 2.66 -4.28 None
Mustang Bio, Inc. MBIO 122.40 None 2.86 -2.49 None
NeuBase Therapeutics, Inc. NBSE 122.22 None 51.35 -2.74 None
TFF Pharmaceuticals, Inc. TFFP 121.60 None 4.71 -3.14 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.36 1.00 10.82 -4.97 None
Milestone Pharmaceuticals, Inc. MIST 96.75 None 0.96 -1.55 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Clearside Biomedical, Inc. CLSD 78.31 6.00 10.05 -4.44 -293.61
Xeris Pharmaceuticals, Inc. XERS 78.12 4.00 3.87 -0.60 None
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Baudax Bio, Inc. BXRX 72.00 None -1.96 -1.03 None
Navidea Biopharmaceuticals, Inc. NAVB 68.34 1.00 -50.25 -6.18 -65.13
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Assertio Therapeutics, Inc. ASRT 59.04 192.00 1.02 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Menlo Therapeutics, Inc. MNLO 49.01 2.00 4.12 -0.52 -483.51
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
CNS Pharmaceuticals, Inc. CNSP 34.48 None 5.99 -6.34 None
Allena Pharmaceuticals, Inc. ALNA 33.70 None 4.44 -0.78 None
Oncternal Therapeutics, Inc. ONCT 33.54 3.00 4.30 -1.33 -225.89
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Aileron Therapeutics, Inc. ALRN 32.48 None 4.46 -1.22 None
Adamis Pharmaceuticals Corp. ADMP 31.90 22.00 1.22 -1.08 -140.33
Acer Therapeutics, Inc. ACER 31.20 3.00 2.28 -1.20 -274.69
Annovis Bio, Inc. ANVS 26.88 None 2.46 -21.33 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.97 None 1.33 -0.47 None
Novus Therapeutics, Inc. NVUS 7.39 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.95 5.00 1.62 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Analysts' Revenue Estimates For Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Are Surging Higher

7d ago, source: YAHOO!

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) shareholders will have a reason to smile today, with the analysts ...

Crinetics Pharmaceuticals Inc

8d ago, source: Bloomberg

Crinetics Pharmaceuticals Inc operates as a clinical stage pharmaceutical company. The Company develops therapeutics for the treatment of endocrine diseases and cancers. Crinetics Pharmaceuticals ...

Chiasma's Valuation Should Be Higher Than $5-6/Share Now That Mycapssa Is FDA Approved

Opinion ago, source: Seeking Alpha

On Friday, June 26, 2020, the FDA approved CHMA's Mycapssa. Shares fell on the news to reflect a market cap of ~$250MM and an ...

Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine

26d ago, source: GlobeNewswire

June 11, 2020 07:30 ET | Source: Crinetics Pharmaceuticals, Inc. 28 patients have completed the open-label Edge trial measuring IGF-1 levels after 13 weeks of treatment when patients with ...

Analysts' Revenue Estimates For Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Are Surging Higher

7d ago, source: Yahoo! News

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts have ...

Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine

26d ago, source: Stockhouse

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases ...

Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine

26d ago, source: Business Insider

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.